#Denmark

🏢Release 📈 Stocks

SimCorp Appoints New Chief Delivery Officer to Drive Client Satisfaction

November 2, 2026 (8 days ago)

SimCorp strengthens its leadership team with a new Chief Delivery Officer role focused on enhancing client satisfaction and operational delivery, leveraging the…

SIM

🌍 EUROPE Read More →

⚡Ad-hoc 📈 Stocks

Sydinvest Updates Prospectus with Risk Indicator Adjustments for 2026

November 2, 2026 (8 days ago)

Sydinvest adjusts risk indicators for its Far East departments and streamlines investment universe descriptions in its latest prospectus update.

SYDINVEST

🌍 EUROPE Read More →

🏛️Filing 🌐 Macro — 📊 Neutral

Nordea Invest Updates Prospectus for High-Yield Corporate Bond Fund

October 30, 2026 (11 days ago)

Nordea Fund Management updates its prospectus for the Virksomhedsobligationer Højrente KL 1 fund, with changes effective as of October 30, 2026.

🌍 EUROPE Read More →

🏢Release 📈 Stocks

HERVolution Validates IPT-001 Pipeline With HERV-K Expression Data

October 28, 2026 (13 days ago)

HERVolution shares gain momentum as new clinical data confirms HERV-K expression in 43 cancer types, validating the therapeutic potential of the company's…

HERVolution

🌍 EUROPE Read More →

🏢Release 📈 Stocks

Genmab Shares Rally as Petosemtamab Trial Cuts Death Risk by 50%

October 28, 2026 (13 days ago)

Genmab's petosemtamab combination therapy significantly improved survival rates in a Phase 3 head and neck cancer trial, meeting dual primary endpoints and…

GMAB

🌍 EUROPE Read More →

🏢Release 📈 Stocks

Novo Nordisk Presents New MASH Data for Wegovy at AASLD Conference

October 28, 2026 (13 days ago)

Novo Nordisk shares new clinical data for Wegovy in MASH treatment, utilizing the PLATINUM-Truveta analysis to benchmark performance against resmetirom and other…

NVO MDGL AKRO

🌍 EUROPE Read More →

🏢Release 📈 Stocks

Per Aarsleff Wins DKK 398 Million Horsens Climate Protection Contract

October 28, 2026 (13 days ago)

Per Aarsleff secures a DKK 398 million contract for a major climate protection and infrastructure project in Horsens, leveraging its expertise in…

AARS

🌍 EUROPE Read More →

⚡Ad-hoc 📈 Stocks

Konsolidator A/S Outlines Capital Restoration Plan After Share Capital Loss

October 27, 2026 (14 days ago)

Konsolidator A/S faces financial distress following a loss of share capital, prompting management to present a restoration plan focused on operational improvements…

KONSOL

🌍 EUROPE Read More →

⚡Ad-hoc 📈 Stocks

BI Management Requests Lifting of Trading Suspension for BankInvest Funds

October 27, 2026 (14 days ago)

BI Management A/S moves to resume trading for BankInvest share classes, signaling a return to normal operations for the affected funds.

BANKINVEST

🌍 EUROPE Read More →

🏢Release 📈 Stocks

Genmab Reports 28.2 Months Median Survival in Phase 2 Head and Neck Cancer Trial

October 26, 2026 (15 days ago)

Genmab's petosemtamab combination therapy shows strong efficacy in Phase 2 trials for head and neck cancer, achieving a 28.2-month median overall survival…

GMAB

🌍 EUROPE Read More →

🏢Release 📈 Stocks

Genmab Reports Strong Phase 2 Data for Petosemtamab in Colorectal Cancer

October 25, 2026 (16 days ago)

Genmab's petosemtamab shows durable clinical activity in metastatic colorectal cancer, with 81% response rates in specific patient subgroups, bolstering the firm's Phase…

GMAB

🌍 EUROPE Read More →

🏢Release 📈 Stocks

Genmab Reports 71% Risk Reduction in Phase 3 Ovarian Cancer Trial

October 23, 2026 (18 days ago)

Genmab's Rina-S hit primary endpoints in a Phase 3 ovarian cancer trial, showing a 71% reduction in disease progression risk and paving…

GMAB

🌍 EUROPE Read More →